Activity and selectivity cliffs for DPP-IV inhibitors: Lessons we can learn from SAR studies and their application to virtual screening
出版年份 2018 全文链接
标题
Activity and selectivity cliffs for DPP-IV inhibitors: Lessons we can learn from SAR studies and their application to virtual screening
作者
关键词
-
出版物
MEDICINAL RESEARCH REVIEWS
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2018-04-17
DOI
10.1002/med.21499
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Ephedrine as a lead compound for the development of new DPP-IV inhibitors
- (2017) María José Ojeda-Montes et al. Future Medicinal Chemistry
- Effect of sitagliptin on plaque changes in coronary artery following acute coronary syndrome in diabetic patients: The ESPECIAL-ACS study
- (2017) Shoichi Kuramitsu et al. Journal of Cardiology
- A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data
- (2017) Evgenia Gourgari et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Protective Effects of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, against Cisplatin-Induced Nephrotoxicity in Mice
- (2017) Seung Hee Choi et al. MEDIATORS OF INFLAMMATION
- Ameliorating Effect of Gemigliptin on Renal Injury in Murine Adriamycin-Induced Nephropathy
- (2017) Da Rae Kim et al. Biomed Research International
- Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas
- (2016) C. F. Deacon et al. DIABETES OBESITY & METABOLISM
- Mechanisms of Cardiovascular Injury in Type 2 Diabetes and Potential Effects of Dipeptidyl Peptidase-4 Inhibition
- (2016) Betsy Dokken Journal of Cardiovascular Nursing
- Discovery and Rational Design of Natural-Product-Derived 2-Phenyl-3,4-dihydro-2H-benzo[f]chromen-3-amine Analogs as Novel and Potent Dipeptidyl Peptidase 4 (DPP-4) Inhibitors for the Treatment of Type 2 Diabetes
- (2016) Shiliang Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- DPP-4 inhibition has beneficial effects on the heart after myocardial infarction
- (2016) Akihiko Kubota et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Improvement of blood glucose levels and obesity in mice given aronia juice by inhibition of dipeptidyl peptidase IV and α-glucosidase
- (2016) Takuya Yamane et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis
- (2016) Marian C Okondo et al. Nature Chemical Biology
- Comparative Binding Analysis of Dipeptidyl Peptidase IV (DPP-4) with Antidiabetic Drugs – An Ab Initio Fragment Molecular Orbital Study
- (2016) Sundaram Arulmozhiraja et al. PLoS One
- NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis
- (2016) Hui Wang et al. Science Translational Medicine
- Response to comment on “NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis”
- (2016) Hui Wang et al. Science Translational Medicine
- Comment on “NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis”
- (2016) Jérémie Decalf et al. Science Translational Medicine
- DPPIV/CD26: a tumor suppressor or a marker of malignancy?
- (2016) Aline Beckenkamp et al. TUMOR BIOLOGY
- Discovery of Novel Tricyclic Heterocycles as Potent and Selective DPP-4 Inhibitors for the Treatment of Type 2 Diabetes
- (2016) Wen-Lian Wu et al. ACS Medicinal Chemistry Letters
- Comprehensive analysis of the Co-structures of dipeptidyl peptidase IV and its inhibitor
- (2016) Hiroyuki Nojima et al. BMC STRUCTURAL BIOLOGY
- The Dose-Dependent Organ-Specific Effects of a Dipeptidyl Peptidase-4 Inhibitor on Cardiovascular Complications in a Model of Type 2 Diabetes
- (2016) Ju-Young Moon et al. PLoS One
- MK-0626, a selective DPP-4 inhibitor, attenuates hepatic steatosis inob/obmice
- (2016) Tatsuya Ohyama et al. WORLD JOURNAL OF GASTROENTEROLOGY
- DPP-IV inhibitor anagliptin exerts anti-inflammatory effects on macrophages, adipocytes, and mouse livers by suppressing NF-κB activation
- (2015) Takanori Shinjo et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Design, Synthesis, and Pharmacological Evaluation of Highly Potent and Selective Dipeptidyl Peptidase-4 Inhibitors
- (2015) Tao Jiang et al. ARCHIV DER PHARMAZIE
- Structure–activity-relationship of amide and sulfonamide analogs of omarigliptin
- (2015) Ping Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Novel 4-Heteroaryl-Antipyrines as DPP-IV Inhibitors
- (2015) Sobhi M. Gomha et al. Chemical Biology & Drug Design
- Synthesis, Biological Evaluation, and Molecular Docking of (R)-2-((8-(3-aminopiperidin-1-yl)-3-methyl-7-(3-methylbut-2-en-1-yl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)methyl)benzonitrile as Dipeptidyl Peptidase IV Inhibitors
- (2015) Yan Ran et al. Chemical Biology & Drug Design
- Suppression of lung metastases by the CD26/DPP4 inhibitor Vildagliptin in mice
- (2015) Jae-Hwi Jang et al. CLINICAL & EXPERIMENTAL METASTASIS
- An Overview of Recent Dipeptidyl Peptidase-IV Inhibitors: Linking their Structure and Physico-Chemical Properties with SAR, Pharmacokinetics and Toxicity
- (2015) Andrija Smelcerovic et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Potential Role of Dipeptidyl Peptidase IV in the Pathophysiology of Heart Failure
- (2015) Thiago Salles et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy
- (2015) Rosa Barreira da Silva et al. NATURE IMMUNOLOGY
- Design, Synthesis, and Pharmacological Evaluation of Fused β-Homophenylalanine Derivatives as Potent DPP-4 Inhibitors
- (2015) Tao Jiang et al. ACS Medicinal Chemistry Letters
- Synthesis of New DPP-4 Inhibitors Based on a Novel Tricyclic Scaffold
- (2015) Carolin Schwehm et al. ACS Medicinal Chemistry Letters
- Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysis
- (2015) Yuichi Terawaki et al. Diabetology & Metabolic Syndrome
- ( R )-3-Amino-1-((3a S ,7a S )-octahydro-1 H -indol-1-yl)-4-(2,4,5-trifluorophenyl)butan-1-one derivatives as potent inhibitors of dipeptidyl peptidase-4: Design, synthesis, biological evaluation, and molecular modeling
- (2014) Sinan Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Structure based virtual screening of MDPI database: Discovery of structurally diverse and novel DPP-IV inhibitors
- (2014) Omprakash Tanwar et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of C-(1-aryl-cyclohexyl)-methylamines as selective, orally available inhibitors of dipeptidyl peptidase IV
- (2014) Kenji Namoto et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Dipeptidyl Peptidase-4 Inhibitors and Cardiovascular Outcomes: Meta-Analysis of Randomized Clinical Trials with 55,141 Participants
- (2014) Shiying Wu et al. Cardiovascular Therapeutics
- Bat Origins of MERS-CoV Supported by Bat Coronavirus HKU4 Usage of Human Receptor CD26
- (2014) Qihui Wang et al. Cell Host & Microbe
- Identification of Dipeptidyl Peptidase IV Inhibitors: Virtual Screening, Synthesis and Biological Evaluation
- (2014) Junhao Xing et al. Chemical Biology & Drug Design
- Cardiovascular Actions of Incretin-Based Therapies
- (2014) John R. Ussher et al. CIRCULATION RESEARCH
- Dipeptidyl Peptidase IV Inhibitors: A New Paradigm in Type 2 Diabetes Treatment
- (2014) Sridhara Janardhan et al. CURRENT DRUG TARGETS
- Dipeptidyl-peptidase 4 Inhibition: Linking Metabolic Control to Cardiovascular Protection
- (2014) Angelo Avogaro et al. CURRENT PHARMACEUTICAL DESIGN
- Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis
- (2014) Yun-A. Jung et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Design, synthesis and biological evaluation of 4-fluoropyrrolidine-2-carbonitrile and octahydrocyclopenta[b]pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors
- (2014) Xun Ji et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of highly potent DPP-4 inhibitors by hybrid compound design based on linagliptin and alogliptin
- (2014) Zeng-Wei Lai et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Recent approaches to medicinal chemistry and therapeutic potential of dipeptidyl peptidase-4 (DPP-4) inhibitors
- (2014) Bhumika D. Patel et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and biological evaluation of hetero-aromatic moieties substituted pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors
- (2014) Xun Ji et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The DPP-IV inhibitor linagliptin and GLP-1 induce synergistic effects on body weight loss and appetite suppression in the diet-induced obese rat
- (2014) Henrik H. Hansen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- DPP-4 inhibitors: pharmacological differences and their clinical implications
- (2014) Antonio Ceriello et al. Expert Opinion On Drug Safety
- Novel DPP-4 inhibitors against diabetes
- (2014) Yang Liu et al. Future Medicinal Chemistry
- Novel hydrazine derivatives as selective DPP-IV inhibitors: findings from virtual screening and validation through molecular dynamics simulations
- (2014) Omprakash Tanwar et al. JOURNAL OF MOLECULAR MODELING
- Atom-based pharmacophore modeling, CoMFA/CoMSIA-based 3D-QSAR studies and lead optimization of DPP-4 inhibitors for the treatment of type 2 diabetes
- (2014) Shailesh V. Jain et al. MEDICINAL CHEMISTRY RESEARCH
- DPP4 inhibition attenuates filtration barrier injury and oxidant stress in the zucker obese rat
- (2014) Ravi Nistala et al. Obesity
- Discovery of Imigliptin, a Novel Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes
- (2014) Chutian Shu et al. ACS Medicinal Chemistry Letters
- New leads for DPP IV inhibition: structure-based pharmacophore mapping and virtual screening study
- (2013) Ihab M. Almasri et al. ARCHIVES OF PHARMACAL RESEARCH
- A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site
- (2013) Mika Nabeno et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Synthesis and biological evaluation of novel benzyl-substituted (S)-phenylalanine derivatives as potent dipeptidyl peptidase 4 inhibitors
- (2013) Yang Liu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of potent dipeptidyl peptidase IV inhibitors through pharmacophore hybridization and hit-to-lead optimization
- (2013) Shaogao Zeng et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and biological evaluation of pyrrolidine-2-carbonitrile and 4-fluoropyrrolidine-2-carbonitrile derivatives as dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes
- (2013) Jiang Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Novel tetrahydropyran analogs as dipeptidyl peptidase IV inhibitors: Profile of clinical candidate (2R,3S,5R)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine (23)
- (2013) Tesfaye Biftu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
- (2013) Nianshuang Wang et al. CELL RESEARCH
- Design and Synthesis of 4-(2,4,5-Trifluorophenyl)butane-1,3-diamines as Dipeptidyl Peptidase IV Inhibitors
- (2013) Linrong Zhu et al. ChemMedChem
- Dipeptidyl peptidase-4 inhibitor reduces infarct size and preserves cardiac function via mitochondrial protection in ischaemia–reperfusion rat heart
- (2013) Kroekkiat Chinda et al. Diabetes & Vascular Disease Research
- Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction
- (2013) P.-H. Groop et al. DIABETES CARE
- Highly potent dipeptidyl peptidase IV inhibitors derived from Alogliptin through pharmacophore hybridization and lead optimization
- (2013) Hui Xie et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The novel dipeptidyl peptidase-4 inhibitor teneligliptin prevents high-fat diet-induced obesity accompanied with increased energy expenditure in mice
- (2013) Sayaka Fukuda-Tsuru et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Berry and Citrus Phenolic Compounds Inhibit Dipeptidyl Peptidase IV: Implications in Diabetes Management
- (2013) Junfeng Fan et al. Evidence-based Complementary and Alternative Medicine
- The importance of synthetic drugs for type 2 diabetes drug discovery
- (2013) Maliheh Safavi et al. Expert Opinion on Drug Discovery
- Dipeptidyl Peptidase IV and Its Inhibitors: Therapeutics for Type 2 Diabetes and What Else?
- (2013) Lucienne Juillerat-Jeanneret JOURNAL OF MEDICINAL CHEMISTRY
- Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis
- (2013) Thomas Klein et al. Medical Molecular Morphology
- Computational studies on structurally diverse dipeptidyl peptidase IV inhibitors: an approach for new antidiabetic drug development
- (2013) Bhumika Patel et al. MEDICINAL CHEMISTRY RESEARCH
- Structure Based Lead Optimization Approach in Discovery of Selective DPP4 Inhibitors
- (2013) Manjunath Ghate et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
- (2013) Guangwen Lu et al. NATURE
- Cardiovascular effects of gliptins
- (2013) André J. Scheen Nature Reviews Cardiology
- ModBase, a database of annotated comparative protein structure models and associated resources
- (2013) Ursula Pieper et al. NUCLEIC ACIDS RESEARCH
- Val-BoroPro Accelerates T Cell Priming via Modulation of Dendritic Cell Trafficking Resulting in Complete Regression of Established Murine Tumors
- (2013) Meghaan P. Walsh et al. PLoS One
- Targeted Inactivation of Dipeptidyl Peptidase 9 Enzymatic Activity Causes Mouse Neonate Lethality
- (2013) Margaret G. Gall et al. PLoS One
- Food protein hydrolysates as a source of dipeptidyl peptidase IV inhibitory peptides for the management of type 2 diabetes
- (2013) Orla Power et al. PROCEEDINGS OF THE NUTRITION SOCIETY
- DPP-IV inhibitors: Beyond glycaemic control?
- (2013) Andrew J. Kwok et al. TRENDS IN CARDIOVASCULAR MEDICINE
- The good, the bad and the dubious: VHELIBS, a validation helper for ligands and binding sites
- (2013) Adrià Cereto-Massagué et al. Journal of Cheminformatics
- Reprint of “On the Size of the Active Site in Proteases. I. Papain”
- (2012) Israel Schechter BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Fused bicyclic heteroarylpiperazine-substituted l-prolylthiazolidines as highly potent DPP-4 inhibitors lacking the electrophilic nitrile group
- (2012) Tomohiro Yoshida et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of 3H-imidazo[4,5-c]quinolin-4(5H)-ones as potent and selective dipeptidyl peptidase IV (DPP-4) inhibitors
- (2012) Yohei Ikuma et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): A highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
- (2012) Tomohiro Yoshida et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Dipeptidyl peptidase-4 inhibitor with β-amino amide scaffold: Synthesis, SAR and biological evaluation
- (2012) Heung Jae Kim et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Long-acting peptidomimetics based DPP-IV inhibitors
- (2012) Pradip Jadav et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Structure-based design of pyridopyrimidinediones as dipeptidyl peptidase IV inhibitors
- (2012) Betty Lam et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis, Structure-Activity Relationship, and Pharmacophore Modeling Studies of Pyrazole-3-Carbohydrazone Derivatives as Dipeptidyl Peptidase IV Inhibitors
- (2012) Deyan Wu et al. Chemical Biology & Drug Design
- Synthesis, Evaluation and Molecular Docking of Thiazolopyrimidine Derivatives as Dipeptidyl Peptidase IV Inhibitors
- (2012) Mani Sharma et al. Chemical Biology & Drug Design
- Recent Advances in Non-Peptidomimetic Dipeptidyl Peptidase 4 Inhibitors: Medicinal Chemistry and Preclinical Aspects
- (2012) Y. Liu et al. CURRENT MEDICINAL CHEMISTRY
- ZINC: A Free Tool to Discover Chemistry for Biology
- (2012) John J. Irwin et al. Journal of Chemical Information and Modeling
- Conformer Generation with OMEGA: Learning from the Data Set and the Analysis of Failures
- (2012) Paul C. D. Hawkins et al. Journal of Chemical Information and Modeling
- FRED and HYBRID docking performance on standardized datasets
- (2012) Mark McGann JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Identification of diverse dipeptidyl peptidase IV inhibitors via structure-based virtual screening
- (2012) Cui Li et al. JOURNAL OF MOLECULAR MODELING
- DPP-4 Inhibition on Top of Angiotensin Receptor Blockade Offers a New Therapeutic Approach for Diabetic Nephropathy
- (2012) Markus L. Alter et al. KIDNEY & BLOOD PRESSURE RESEARCH
- The RCSB Protein Data Bank: new resources for research and education
- (2012) Peter W. Rose et al. NUCLEIC ACIDS RESEARCH
- Dipeptidyl-peptidase-IV by cleaving neuropeptide Y induces lipid accumulation and PPAR-γ expression
- (2012) Joana Rosmaninho-Salgado et al. PEPTIDES
- Identification of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin (Part II): In Silico Prediction in Antidiabetic Extracts
- (2012) Laura Guasch et al. PLoS One
- Identification of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin (Part I): Virtual Screening and Activity Assays
- (2012) Laura Guasch et al. PLoS One
- Discovery of potent, selective, and orally bioavailable quinoline-based dipeptidyl peptidase IV inhibitors targeting Lys554
- (2011) Hironobu Maezaki et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Identification of 3-aminomethyl-1,2-dihydro-4-phenyl-1-isoquinolones: A new class of potent, selective, and orally active non-peptide dipeptidyl peptidase IV inhibitors that form a unique interaction with Lys554
- (2011) Yoshihiro Banno et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes
- (2011) Jon M. Sutton et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Diet-Induced Adipose Tissue Inflammation and Liver Steatosis Are Prevented by DPP-4 Inhibition in Diabetic Mice
- (2011) J. Shirakawa et al. DIABETES
- Recent patents of dipeptidyl peptidase IV inhibitors
- (2011) Laura Mendieta et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- FRED Pose Prediction and Virtual Screening Accuracy
- (2011) Mark McGann Journal of Chemical Information and Modeling
- Discovery of a 3-Pyridylacetic Acid Derivative (TAK-100) as a Potent, Selective and Orally Active Dipeptidyl Peptidase IV (DPP-4) Inhibitor
- (2011) Yasufumi Miyamoto et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure–Activity Relationship Studies on Isoindoline Inhibitors of Dipeptidyl Peptidases 8 and 9 (DPP8, DPP9): Is DPP8-Selectivity an Attainable Goal?
- (2011) Sebastiaan Van Goethem et al. JOURNAL OF MEDICINAL CHEMISTRY
- Possible ligand release pathway of dipeptidyl peptidase IV investigated by molecular dynamics simulations
- (2011) Cui Li et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Fast and effective identification of the bioactive compounds and their targets from medicinal plants via computational chemical biology approach
- (2011) Shoude Zhang et al. MedChemComm
- Hydrophilic residues surrounding the S1 and S2 pockets contribute to dimerisation and catalysis in human dipeptidyl peptidase 8 (DP8)
- (2010) Melissa R. Pitman et al. BIOLOGICAL CHEMISTRY
- Design and synthesis of 3-pyridylacetamide derivatives as dipeptidyl peptidase IV (DPP-4) inhibitors targeting a bidentate interaction with Arg125
- (2010) Yasufumi Miyamoto et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database
- (2010) Paul C. D. Hawkins et al. Journal of Chemical Information and Modeling
- Design and Synthesis of Pyrimidinone and Pyrimidinedione Inhibitors of Dipeptidyl Peptidase IV
- (2010) Zhiyuan Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Biochemistry, pharmacokinetics, and toxicology of a potent and selective DPP8/9 inhibitor
- (2009) Jia-Jing Wu et al. BIOCHEMICAL PHARMACOLOGY
- Dipeptidyl peptidase 9 (DPP9) from bovine testes: Identification and characterization as the short form by mass spectrometry
- (2009) Véronique Dubois et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes
- (2009) Shrikanth H. Havale et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of β-homophenylalanine based pyrrolidin-2-ylmethyl amides and sulfonamides as highly potent and selective inhibitors of dipeptidyl peptidase IV
- (2009) Sonja Nordhoff et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of carmegliptin: A potent and long-acting dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
- (2009) Patrizio Mattei et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease
- (2009) Angela Pennisi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Medicinal Chemistry of Incretin Mimetics and DPP-4 Inhibitors
- (2009) Heiko Zettl et al. ChemMedChem
- Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition
- (2009) Mark Kirby et al. CLINICAL SCIENCE
- DPP-IV inhibition enhances the antilipolytic action of NPY in human adipose tissue
- (2009) K. Kos et al. DIABETES OBESITY & METABOLISM
- Novel Method for Generating Structure-Based Pharmacophores Using Energetic Analysis
- (2009) Noeris K. Salam et al. Journal of Chemical Information and Modeling
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- (2009) Garrett M. Morris et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
- (2009) Roger Yazbeck et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 1: Identification of dipeptide derived leads
- (2008) Pieter Van der Veken et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Structure-based design and synthesis of benzimidazole derivatives as dipeptidyl peptidase IV inhibitors
- (2008) Michael B. Wallace et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Fluoroolefins as amide bond mimics in dipeptidyl peptidase IV inhibitors
- (2008) Scott D. Edmondson et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- PDTD: a web-accessible protein database for drug target identification
- (2008) Zhenting Gao et al. BMC BIOINFORMATICS
- FAF-Drugs2: Free ADME/tox filtering tool to assist drug discovery and chemical biology projects
- (2008) David Lagorce et al. BMC BIOINFORMATICS
- Discovery of DPP IV Inhibitors by Pharmacophore Modeling and QSAR Analysis followed by in silico Screening
- (2008) Ihab M. Al-masri et al. ChemMedChem
- Medicinal Chemistry Approaches to the Inhibition of Dipeptidyl Peptidase IV
- (2008) Stephen Gwaltney II CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Adverse effects of dipeptidyl peptidases 8 and 9 inhibition in rodents revisited
- (2008) B. F. Burkey et al. DIABETES OBESITY & METABOLISM
- Dipeptidyl Aminopeptidase IV from Stenotrophomonas maltophilia Exhibits Activity against a Substrate Containing a 4-Hydroxyproline Residue
- (2008) Y. Nakajima et al. JOURNAL OF BACTERIOLOGY
- Involvement of DPP-IV catalytic residues in enzyme-saxagliptin complex formation
- (2008) William J. Metzler et al. PROTEIN SCIENCE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started